Oxidation of (14)C-labeled compounds perfused by microdialysis in the brains of free-moving rats
Data analysis/interpretation of data: JS, AW, AD, DGB, EIC, SRW, MBS, BH, CEM, PJR, LDB
Ferreira CF, Bernardi JR, Krolow R, Arcego DM, Fries GR, de Aguiar BW, et al
Italy: Growing Private Sector, Limited Public Funding In Italy: Wegovy and Saxenda are both approved for obesity treatment Most people get these medicines through private doctors Public healthcare may cover these medicines in exceptional cases, but only for people with very severe obesity and serious health problems National rules are slowly changing, but public coverage is still limited and not consistent across the country Private costs in Italy: About 250 to 350 per month for Wegovy About 200 to 300 per month for Saxenda Who prescribes GLP-1s in Italy